Capital One initiated coverage of Immunocore with an Overweight rating and $84 price target.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IMCR:
- Immunocore price target raised to $91 from $85 at BTIG
- Immunocore price target raised to $75 from $72 at Oppenheimer
- Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
- Immunocore reports Q2 EPS (37c), consensus (41c)
- Immunocore to report second quarter 2023 financial results and host call on August 10, 2023